Seikagaku and Ono Pharmaceutical submitted a new drug application for manufacturing and marketing approval for ONO-5704/SI-613 injectable in Japan for the treatment of...
OrthoPediatrics commenced U.S. launch of QuickPack™ synthetic bone graft substitute....
Bioventus secured preferred access to DUROLANE, GELSYN-3 and SUPARTZ FX to treat knee OA pain for certain Blue Cross Blue Shield of Michigan patients. ...
In2Bones commenced global launch of the AlloAid BioNail™ engineered allograft implant for reconstructive surgery of the hand and foot....
Hensler Surgical filed a lawsuit against Tobra Medical, alleging patent infringement relative to the Tobra Medical Bone Basket....
Anika Therapeutics is commencing full U.S. commercial launch of TACTOSET surgically-delivered therapy for bone repair procedures....
FDA approved Cerapedics' Premarket Approval supplement for i-FACTOR® Peptide Enhanced Bone Graft for use in ACDF to treat degenerative cervical disc disease....
Personalized Stem Cells treated the first patients in an FDA-approved clinical trial for stem cell treatment of knee osteoarthritis....
In2Bones commenced U.S. launch of the CoLink® Bone Graft Harvester and Tribio™ Backfill Plug System....
GID BIO completed a Phase IIb clinical trial using autologous stromal cells in the treatment of knee osteoarthritis....
0 
